Title of article :
Premature pubarche as a first presentation of pituitary macroprolactinoma
Author/Authors :
Tabatabaei, Fatemeh Clinical Research Development Research Centre - Najafabad Branch Islamic Azad University, Najafabad, Iran , Sharif, Mohammad Reza Infectious Diseases Research Center - Kashan University of Medical Sciences, Kashan, Iran , Nasr Esfahani, Hossein Depatment of Ophthalmology - School of Medicine - Najafabad University - Shariati Hospital, Isfahan, Iran , Yazdi Zahrani, Razieh Isfahan Clinical Toxicology Research Center - Isfahan University of Medical Sciences, Isfahan, Iran , Taheri, Abolfazl 5Health Information Technology Research Center - Clinical Information’s Research Group - Isfahan University of Medical Sciences, Isfahan, Iran , Meamar, Rokhsareh Isfahan Clinical Toxicology Research Center - Isfahan University of Medical Sciences, Isfahan, Iran
Abstract :
Prolactinoma is a rare tumor of childhood. Clinical presentations of prolactinoma include amenorrhea, delayed puberty, and
galactorrhea. For the first time, in this case, elevated prolactin levels were associated with unexpected premature pubarche. We
describe an 8‑year, 7‑month‑old boy with acne and gradual appearance of pubic hair, corresponding to tanner stage 2. Hormonal
tests showed severe hyperprolactinemia (prolactin = 246.8 μg/L and pooled prolactin = 175 μg/L and macroprolactin = 5 μg/L) and
mildly elevated level of dehdroepiandrostenedion sulfate (DHEAS) and testosterone. Magnetic resonance imaging (MRI) findings
confirmed the presence of a pituitary macroprolactinoma, measuring 14 mm × 12 mm × 8 mm on the right side of the pituitary
gland. Cabergoline therapy was commenced (0.5 mg/week) and after 3 months, no evidence of pubarche progression was observed.
Prolactin level and tumor size markedly reduced. At the 9‑month follow‑up visit, a normal MRI was reported. This case highlights
that even when facing premature pubarche, careful examination is mandatory, and if no obvious etiology is found for premature
pubarche, clinicians should consider prolactinoma.
Keywords :
puberty , prolactinoma , precocious puberty , dehdroepiandrostenedion sulfate (DHEAS) , child/growth and development , child , Adrenarche
Journal title :
Journal of Research in Medical Sciences